
Sintx Technologies, Inc. (NASDAQ:SINT – Free Report) – Research analysts at HC Wainwright lifted their Q3 2026 earnings per share (EPS) estimates for Sintx Technologies in a report issued on Thursday, August 13th. HC Wainwright analyst B. Folkes now anticipates that the company will post earnings per share of ($0.28) for the quarter, up from their previous forecast of ($0.43). HC Wainwright currently has a “Buy” rating and a $10.00 target price on the stock. The consensus estimate for Sintx Technologies’ current full-year earnings is ($1.67) per share. HC Wainwright also issued estimates for Sintx Technologies’ Q4 2026 earnings at ($0.38) EPS, FY2026 earnings at ($1.67) EPS, FY2027 earnings at ($1.12) EPS, FY2028 earnings at ($0.57) EPS, FY2029 earnings at $1.01 EPS and FY2030 earnings at $1.56 EPS.
Sintx Technologies (NASDAQ:SINT – Get Free Report) last posted its quarterly earnings data on Tuesday, August 11th. The company reported ($0.75) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.73) by ($0.02). Sintx Technologies had a negative net margin of 848.20% and a negative return on equity of 354.44%. The firm had revenue of $0.45 million during the quarter, compared to analysts’ expectations of $0.46 million.
Check Out Our Latest Stock Report on SINT
Sintx Technologies Stock Performance
Shares of Sintx Technologies stock opened at $1.62 on Monday. The business has a 50-day moving average of $1.77 and a 200 day moving average of $2.32. Sintx Technologies has a 12 month low of $1.40 and a 12 month high of $6.78.
Institutional Trading of Sintx Technologies
An institutional investor recently raised its position in Sintx Technologies stock. Geode Capital Management LLC lifted its stake in Sintx Technologies, Inc. (NASDAQ:SINT – Free Report) by 33.5% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 15,339 shares of the company’s stock after purchasing an additional 3,848 shares during the period. Geode Capital Management LLC owned about 0.56% of Sintx Technologies worth $49,000 at the end of the most recent quarter. 18.38% of the stock is currently owned by hedge funds and other institutional investors.
Sintx Technologies Company Profile
Sintx Technologies, Inc (NASDAQ: SINT) is a medical materials company specializing in the development and manufacture of silicon nitride-based biomaterials for surgical and implantable medical devices. Its proprietary silicon nitride ceramic combines mechanical strength, biocompatibility and intrinsic antimicrobial properties, positioning it as an alternative to traditional metal and polymer implant materials. Sintx’s primary focus is on applications in spinal fusion, trauma fixation and dental implantology, where device performance and long-term biological response are critical.
The company’s core product offerings include silicon nitride powders for advanced implant fabrication and finished implantable components designed for interbody spinal fusion cages, spinal fixation hardware and trauma plates and screws.
Recommended Stories
- Five stocks we like better than Sintx Technologies
- The AI Boom Is Turning This Cable Maker Into a Stock to Watch
- A Star Investor Just Trimmed Amazon—Here’s What It means
- Wendy’s Deal Buzz May Give Fast-Food Investors a New Reason to Look
- Home Depot Analysts See a Path to $375 and Beyond
Receive News & Ratings for Sintx Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sintx Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
